187 related articles for article (PubMed ID: 36420774)
1. Immunotherapy approaches for rare pediatric solid tumors: advances and future directions.
Fierro Pineda JC; Wedekind MF; Glod JW
Curr Opin Pediatr; 2023 Feb; 35(1):63-74. PubMed ID: 36420774
[TBL] [Abstract][Full Text] [Related]
2. New developments in immunotherapy for pediatric solid tumors.
Schultz LM; Majzner R; Davis KL; Mackall C
Curr Opin Pediatr; 2018 Feb; 30(1):30-39. PubMed ID: 29189429
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of Pediatric Solid Tumors: Treatments at a Crossroads, with an Emphasis on Antibodies.
Casey DL; Cheung NV
Cancer Immunol Res; 2020 Feb; 8(2):161-166. PubMed ID: 32015013
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapies for Pediatric Solid Tumors: A Targeted Update.
Gupta A; Cripe TP
Paediatr Drugs; 2022 Jan; 24(1):1-12. PubMed ID: 34822115
[TBL] [Abstract][Full Text] [Related]
5. Emerging vistas in CAR T-cell therapy: challenges and opportunities in solid tumors.
Date V; Nair S
Expert Opin Biol Ther; 2021 Feb; 21(2):145-160. PubMed ID: 32882159
[TBL] [Abstract][Full Text] [Related]
6. CAR-T Therapies in Solid Tumors: Opportunities and Challenges.
Guzman G; Reed MR; Bielamowicz K; Koss B; Rodriguez A
Curr Oncol Rep; 2023 May; 25(5):479-489. PubMed ID: 36853475
[TBL] [Abstract][Full Text] [Related]
7. Immunometabolism: A 'Hot' Switch for 'Cold' Pediatric Solid Tumors.
Xiao L; Yeung H; Haber M; Norris MD; Somers K
Trends Cancer; 2021 Aug; 7(8):751-777. PubMed ID: 34183305
[TBL] [Abstract][Full Text] [Related]
8. From a Patient Advocate's Perspective: Does Cancer Immunotherapy Represent a Paradigm Shift?
Madden DL
Curr Oncol Rep; 2018 Feb; 20(1):8. PubMed ID: 29411148
[TBL] [Abstract][Full Text] [Related]
9. Targeting tumor microenvironment and metastasis in children with solid tumors.
Wessel KM; Kaplan RN
Curr Opin Pediatr; 2022 Feb; 34(1):53-60. PubMed ID: 34812775
[TBL] [Abstract][Full Text] [Related]
10. The current landscape of immunotherapy for pediatric brain tumors.
Hwang EI; Sayour EJ; Flores CT; Grant G; Wechsler-Reya R; Hoang-Minh LB; Kieran MW; Salcido J; Prins RM; Figg JW; Platten M; Candelario KM; Hale PG; Blatt JE; Governale LS; Okada H; Mitchell DA; Pollack IF
Nat Cancer; 2022 Jan; 3(1):11-24. PubMed ID: 35121998
[TBL] [Abstract][Full Text] [Related]
11. Immune cell engagers in solid tumors: promises and challenges of the next generation immunotherapy.
Fucà G; Spagnoletti A; Ambrosini M; de Braud F; Di Nicola M
ESMO Open; 2021 Feb; 6(1):100046. PubMed ID: 33508733
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for Pediatric Brain and Spine Tumors: Current State and Future Directions.
Estevez-Ordonez D; Gary SE; Atchley TJ; Maleknia PD; George JA; Laskay NMB; Gross EG; Devulapalli RK; Johnston JM
Pediatr Neurosurg; 2023; 58(5):313-336. PubMed ID: 36549282
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for the treatment of pediatric brain tumors: a narrative review.
Shalita C; Hanzlik E; Kaplan S; Thompson EM
Transl Pediatr; 2022 Dec; 11(12):2040-2056. PubMed ID: 36643672
[TBL] [Abstract][Full Text] [Related]
14. Characterization of MHC Class I and β-2-Microglobulin Expression in Pediatric Solid Malignancies to Guide Selection of Immune-Based Therapeutic Trials.
Haworth KB; Arnold MA; Pierson CR; Leddon JL; Kurmashev DK; Swain HM; Hutzen BJ; Roberts RD; Cripe TP
Pediatr Blood Cancer; 2016 Apr; 63(4):618-26. PubMed ID: 26575538
[TBL] [Abstract][Full Text] [Related]
15. Challenges and next steps in the advancement of immunotherapy: summary of the 2018 and 2020 National Cancer Institute workshops on cell-based immunotherapy for solid tumors.
Fogli LK; Aurigemma R; Sommers CL; Singh A; Bourcier K; Ernstoff MS;
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34266886
[TBL] [Abstract][Full Text] [Related]
16. Cellular immunotherapy for pediatric solid tumors.
Hegde M; Moll AJ; Byrd TT; Louis CU; Ahmed N
Cytotherapy; 2015 Jan; 17(1):3-17. PubMed ID: 25082406
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoconjugates in the age of modern immuno-oncology.
Nasr D; Kumar PA; Zerdan MB; Ghelani G; Dutta D; Graziano S; Lim SH
Life Sci; 2022 Dec; 310():121126. PubMed ID: 36309222
[TBL] [Abstract][Full Text] [Related]
18. Clinical advances in oncolytic virotherapy for pediatric brain tumors.
Ghajar-Rahimi G; Kang KD; Totsch SK; Gary S; Rocco A; Blitz S; Kachurak K; Chambers MR; Li R; Beierle EA; Bag A; Johnston JM; Markert JM; Bernstock JD; Friedman GK
Pharmacol Ther; 2022 Nov; 239():108193. PubMed ID: 35487285
[TBL] [Abstract][Full Text] [Related]
19. Highlights of the second international conference on "Immunotherapy in Pediatric Oncology".
Capitini CM; Gottschalk S; Brenner M; Cooper LJ; Handgretinger R; Mackall CL
Pediatr Hematol Oncol; 2011 Sep; 28(6):459-60. PubMed ID: 21854215
[TBL] [Abstract][Full Text] [Related]
20. Harnessing immunotherapy for pediatric T-cell malignancies.
Diorio C; Teachey DT
Expert Rev Clin Immunol; 2020 Apr; 16(4):361-371. PubMed ID: 32103690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
